Winton Group LTD Assertio Holdings, Inc. Transaction History

Winton Group LTD

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Feb 12, 2024	SELL	$1.02 - $2.57 $20,604 - $51,914	-20,200 Reduced 13.6%	128,356 $137,000
Q3 2023 Nov 13, 2023	BUY	$2.52 - $5.69 $201,441 - $454,841	79,937 Added 116.49%	148,556 $380,000
Q2 2023 Aug 14, 2023	BUY	$5.0 - $7.66 $343,095 - $525,621	68,619 New	68,619 $371,000
Q4 2021 Feb 10, 2022	SELL	$0.86 - $2.3 $32,274 - $86,314	-37,528 Closed	0 $0
Q3 2021 Oct 28, 2021	BUY	$0.89 - $1.55 $3,183 - $5,544	3,577 Added 10.54%	37,528 $34,000
Q2 2021 Aug 10, 2021	BUY	$1.48 - $2.88 $50,247 - $97,778	33,951 New	33,951 $53,000

114

37.2M

755K

39.5K

Ticker ASRT
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 48,178,200
Market Cap $58.8M
Description
Assertio Holdings, Inc., a specialty pharmaceutical company, provides medicines in the areas of neurology, hospital, and pain and inflammation. Its pharmaceutical products include INDOCIN, an oral solution and a suppository form for the treatment of moderate to severe rheumatoid arthritis, including acute flares of chronic disease; ankylosing sp...

Get notified when there are updates to the investment portfolio of Winton Group LTD, based on Form 13F filings with the SEC.

Stay updated on Winton Group LTD with notifications on news.